Abeona Therapeutics Inc.

Ownership Transactions Reported by 17 Insiders

Symbol
ABEO on Nasdaq
Location
6555 Carnegie Ave, 4 Th Floor, Cleveland, OH

Insiders trading volume in the past year

Abeona Therapeutics Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Adage Capital Management, L.P. 10%+ Owner $12M +$12M May 7, 2024
Vishwas Seshadri Chief Executive Officer, Director $7.04M +$32K +0.46% Jan 21, 2025
Steven H. Rouhandeh Director, 10%+ Owner $2.73M May 25, 2021
Joseph Vazzano Chief Financial Officer $2.6M +$17.6K +0.68% Jan 21, 2025
Edward Carr Chief Financial Officer $2.04M Oct 8, 2021
Brendan O'Malley SVP, General Counsel $2.04M +$27.9K +1.39% Mar 3, 2025
Michael Amoroso Director $971K Jan 31, 2025
Leila Alland Director $830K +$51.8K +6.65% Jan 31, 2025
Donald A. Wuchterl Director $810K Jan 31, 2025
Faith L. Charles Director $806K +$24.8K +3.17% Jan 31, 2025
Christine Berni Silverstein Director $719K -$116K -13.9% Jan 31, 2025
Mark Alvino Director $540K -$159K -22.7% Jan 31, 2025
Bernhardt Zeiher Director $254K Jan 31, 2025
Eric Crombez Director $254K Jan 31, 2025
Todd Wider Director $86.4K Sep 26, 2022
Paul Elliot Mann Director $86.4K Sep 26, 2022
Adage Capital Partners Gp, L.L.C. 10%+ Owner Jul 3, 2023

Recent Insider Transactions by Companies or Individuals for Abeona Therapeutics Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.